imugene celularity announce an exclusive strategic partnership to develop a novel oncolytic virus.
Published 3 years ago • 3.6K plays • Length 29:19Download video MP4
Download video MP3
Similar videos
-
3:24
imugene limited tapping breast cancer market via oncolytic virus checkvacc
-
4:07
combination car t oncolytic virus immunotherapy kills tumors
-
30:02
imugene's science series featuring the oncolytic viraltherapy checkvacc
-
6:16
imugene's new cancer therapy cd19 (oncarlytics) considered the 'holy grail'
-
5:35
imugene's leslie chong outlines key strategic partnership with celularity
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
26:56
investor presentation post asx news: imugene and eureka therapeutics oncarlytics collaboration
-
32:59
imugene's science series: pd1-vaxx | b cell immunotherapy
-
19:06
imugene's founder and executive chairman's keynote speech at emerging small caps summit 2021
-
20:11
interview with the cf33 oncolytic virus inventor - imugene (imu)
-
20:44
killing cancer with viruses? by professor yuman fong, inventor of oncolytic virus cf33
-
5:15
imugene featured on behind the scenes with host laurence fishburne.
-
8:29
imugene's leslie chong details eureka therapeutics collaboration
-
4:11
imugene limited (asx: imu) | snn network
-
14:02
imugene (asx: imu) – new global partnership announced for this leading asx biotech
-
4:12
imugene's ceo interviewed on ausbiz detailing a clinical trial deal with merck germany and pfizer.
-
0:36
imugene's science series: checkvacc with professor yuman fong and dr. yuan yuan.
-
1:24
channel 7 news exclusive: imugene licenses car t directed ov therapy for solid tumours
-
25:53
imugene presentation – nwr virtual investor conference (series 8)
-
16:12
a clinical stage immuno-oncology company.
-
4:45
leslie chong's first interview following our news imugene secured two fda ind approvals
-
1:26
channel 7 news exclusive